COMMUNIQUÉS West-GlobeNewswire

-
Allscripts to release fourth-quarter and full-year 2018 financial results February 21
22/01/2019 -
Allscripts offers free pharmacogenomics testing to U.S.-based associates
22/01/2019 -
HempAmericana Commences Full-Scale Production with Significant Purchase Order for CBD Distillate
22/01/2019 -
Cocrystal Pharma Provides Update on Clinical Development Program Evaluating CC-31244 for Ultra-Short Treatment of Hepatitis C Virus
22/01/2019 -
Vystar® Begins Soft Launch of Vytex® Cloud Bed-in-a-Box via Rotmans
22/01/2019 -
Tower One Announces Debt Financing and Update on Tower Deployments
22/01/2019 -
InspireMD Announces Results from Initial Clinical Study of The CGuard™ Embolic Prevention System (EPS) with SmartFit™ Technology
22/01/2019 -
PetMed Express D/B/A 1-800-PetMeds Announces Its Third Quarter Financial Results and Declares Its $0.27 Per Share Dividend
22/01/2019 -
HealthLynked signs Definitive Agreement to Acquire HCFM, Adding Significant Revenue to its Health Services Division
22/01/2019 -
Spectral Announces Distribution Agreement for its Proprietary CRRT Machine
22/01/2019 -
Attune Pharmaceuticals Announces Positive Phase 1 Results for ATN-249, an Oral Plasma Kallikrein Inhibitor for the Treatment of HAE
22/01/2019 -
Apollomics, Inc. Strengthens Leadership with Key Hires
22/01/2019 -
DiaMedica Therapeutics Announces Publication of a Paper, “Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke,” in the Journal Therapeutic Advances in Neurological Disorders
22/01/2019 -
Orchard Announces Publication by San Raffaele-Telethon Institute for Gene Therapy of OTL-300 Clinical Data for the Treatment of Transfusion-Dependent Beta-Thalassemia in Nature Medicine
22/01/2019 -
Rexahn Presents Updated Preliminary Data on RX-3117 in Pancreatic Cancer at the 2019 ASCO GI Symposium
22/01/2019 -
Onconova Therapeutics, Inc. to Present at the NobleCON 15th Annual Investor Conference in Fort Lauderdale, FL
22/01/2019 -
Translate Bio Announces FDA Clinical Hold on Investigational New Drug Application (IND) for MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency
22/01/2019 -
Cytokinetics Announces Receipt of FDA Feedback Regarding Reldesemtiv in Patients With SMA
22/01/2019 -
BioCorRx Awarded NIDA Grant of Approximately $5.7 Million for BICX102, a Sustained Release Naltrexone Implant for the Treatment of Opioid Use Disorder
22/01/2019
Pages